Top news of the week: 08.08.2022.
Health care
Strategic management
Graves' disease
Autoimmune disease
Medicine
Vice President of the United States
RT @SofiaGuerraR: 🚨 Launch alert! @stephenkraus and I took a deep dive into 50+ private and public🩺businesses to give you the lowdown on what it looks like to build a ‘best-in-class’ health tech business https://t.co/ZiucEdunp5
Open
Benchmarks for growing health tech businesses
Benchmarks and insights on how healthcare technology businesses grow into successful companies
ChemoCentryx traded 110% higher after reporting it agreed to be acquired by Amgen in an all-cash deal valued at $4B.
ChemoCentryx Shares Double on $4B Cash Bid from Amgen: https://t.co/I3xMxaYSG7
$CCXI $AMGN #inflammation #nephrology #stocks #MandA @chemocentryxinc @Amgen
OpenChemoCentryx Shares Double on $4B Cash Bid from Amgen Trending Company
Shares of ChemoCentryx Inc. traded 110% higher after the company reported it agreed to be acquired by Amgen Inc. for $52.00 per share in an all-cash deal valued at $4 billion. With the ...
RT @Jasonmmast: Always admired @levfacher for his hard reporting on capitol hill. But this one, is kinda, um, hysterical?
Cities are lobbying to host the ARPA-H headquarters. Experts — including Francis Collins — are utterly baffled
https://t.co/F8sKeh45ng
Open
Cities are lobbying to host the ARPA-H headquarters. Experts don’t understand why
Cities and states are lobbying hard to bring ARPA-H to their backyard. But experts say it won’t be the economic boon they’re hoping for.